S. B. Kaye

The effect of cytotoxic therapy on saliva and oral flora

B.E. Main, Kenneth C. Calman, M.M. Ferguson et al. · Oral Surgery Oral Medicine Oral Pathology · 1984 · 93 citations

Dentistry, Oral Biology, Periodontics +14

AZD2281 (KU-0059436), a PARP (poly ADP-ribose polymerase) inhibitor with single agent anticancer activity in patients with BRCA deficient ovarian cancer: Results from a phase I study

Peter C.C. Fong, David S. Boss, C. P. Carden et al. · Journal of Clinical Oncology · 2008 · 83 citations

Medicine, Oncology, Pharmacology +17

The oral carriage of yeasts and coliforms in patients on cytotoxic therapy

LP Samaranayake, Kenneth C. Calman, M.M. Ferguson et al. · Journal of Oral Pathology and Medicine · 1984 · 61 citations

Dentistry, Oral Biology, Medical Microbiology +9

Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?

M. Harding, J McAllister, G Hulks et al. · British Journal of Cancer · 1990 · 61 citations · Full text

Medicine, Cell Biology, Oncology +8

First-in-human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients with antitumor activity in BRCA-deficient tumors and sporadic ovarian cancers (soc).

William R. Schelman, Shahneen Sandhu, G. Wilding et al. · Journal of Clinical Oncology · 2011 · 57 citations

Medicine, Oncology, Pharmacology +15